Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Synergism between halothane and labetalol.

J M Hunter

    Anaesthesia
    |March 1, 1979
    PubMed
    Summary
    This summary is machine-generated.

    Labetalol combined with low-dose halothane anesthesia caused severe heart depression in a renal failure patient. This suggests caution is needed when using halothane in patients with prior heart damage.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Neuromuscular blocking drugs in the critically ill.

    BJA education·2021
    Same author

    Reversal of neuromuscular block.

    BJA education·2021
    Same author

    The many contributions of WW Mapleson to the British Journal of Anaesthesia.

    British journal of anaesthesia·2019
    Same author

    Tracheal intubation without the use of neuromuscular blocking drugs. Reply to Br J Anaesth 2018; 121: e9-10.

    British journal of anaesthesia·2018
    Same author

    Should neuromuscular blocking agents always be used for tracheal intubation? Reply to Br J Anaesth 2018; 122: e8-9.

    British journal of anaesthesia·2018
    Same author

    Dr J. Edmund Riding CBE, MD, FRCA, FRCS (Hon), FCARCSI (Hon), FANZCA (Hon): 1924-2018.

    British journal of anaesthesia·2018

    Area of Science:

    • Anesthesiology
    • Nephrology
    • Cardiology

    Background:

    • Combined alpha- and beta-blocking agent labetalol is used in patients with chronic renal failure.
    • Renal transplantation is a treatment option for patients with chronic renal failure.
    • Halothane is an inhalational anesthetic agent.

    Observation:

    • A patient with chronic renal failure on high-dose labetalol underwent renal transplantation.
    • Low concentrations of halothane were used for anesthesia induction and maintenance.
    • Severe myocardial depression occurred during anesthesia.

    Findings:

    • The myocardial depression was unresponsive to atropine and isoprenaline.
    • Dopamine infusion successfully treated the myocardial depression.

    Related Experiment Videos

  • This case suggests a potential fatal synergism between labetalol and low-dose halothane in patients with prior myocardial damage.

    • Implications:

    • Clinicians should exercise extreme caution when using halothane in patients with chronic renal failure and prior myocardial damage, especially if they are on labetalol.
    • Lower concentrations of halothane than previously thought may cause adverse cardiac events in susceptible patients.
    • Further research is warranted to understand the synergistic effects of labetalol and halothane on myocardial function.